National Science COVAXIN, developed by ICMR & Bharat Biotech, shows 81% efficacy Observer Voice Team March 3, 2021
Featured National Science BARC develops Eye Cancer therapy in the form of the indigenous Ruthenium 106 Observer Voice Team February 21, 2021
